| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 80.84B | 80.18B | 73.03B | 67.66B | 64.99B | 61.61B |
| Gross Profit | 34.57B | 34.95B | 31.62B | 29.09B | 25.91B | 26.66B |
| EBITDA | 27.51B | 28.17B | 26.30B | 22.25B | 19.83B | 20.04B |
| Net Income | 13.77B | 14.36B | 13.59B | 10.49B | 8.87B | 9.23B |
Balance Sheet | ||||||
| Total Assets | 192.74B | 184.91B | 172.80B | 163.62B | 158.28B | 151.62B |
| Cash, Cash Equivalents and Short-Term Investments | 55.47B | 53.66B | 52.90B | 54.81B | 61.06B | 62.98B |
| Total Debt | 74.63B | 66.53B | 61.20B | 66.78B | 79.81B | 80.63B |
| Total Liabilities | 97.32B | 90.22B | 84.78B | 84.64B | 98.21B | 98.38B |
| Stockholders Equity | 94.35B | 94.27B | 87.56B | 78.49B | 59.74B | 52.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.67B | 8.55B | 3.33B | 386.00M | -3.16B |
| Operating Cash Flow | 0.00 | 23.02B | 21.67B | 16.27B | 18.05B | 11.41B |
| Investing Cash Flow | 0.00 | -18.96B | -15.56B | -12.30B | -16.45B | -14.58B |
| Financing Cash Flow | 0.00 | -3.54B | -7.64B | -8.97B | -3.17B | 1.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥81.63B | 5.37 | ― | 2.77% | 24.61% | 185.90% | |
73 Outperform | ¥391.08B | 25.34 | ― | 1.30% | 8.33% | 1.73% | |
73 Outperform | ¥187.90B | 17.30 | 11.00% | 2.20% | 6.63% | -3.05% | |
73 Outperform | ¥28.86B | 7.02 | ― | 2.62% | -9.37% | 590.66% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥280.22B | 7.02 | ― | 3.14% | 22.74% | -28.17% |